Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus

Huei Jyh Fahn, Liang Shun Wang, Biing Shiun Huang, Min Hsiung Huang, Kwang Yu Chien

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

To evaluate the status of tumor, recurrence and the possible factors relevant to tumor recurrence among patients who survived more than 5 years after subtotal esophagectomy for the treatment of squamous cell carcinoma of the esophagus, a total of 104 patients who received treatment between 1959 and 1986 were reviewed. In 18 of these 104 patients, local or distant tumor recurrence developed, for a tumor recurrence rate of 17.3%. Eleven (61.1%) of these 18 patients eventually died of carcinomatosis despite further radiotherapy or chemotherapy, or both, and 4 patients with the disease are still alive. Three patients continue to survive after aggressive therapy was instituted for control of the locally recurrent tumor. Sixty-nine of the 104 patients are alive without tumor recurrence after the initial esophagectomy, and the remaining 17 patients died of miscellaneous causes. Tumor recurrence appears to be the most important factor affecting the prognosis in long-term survivors with resectable esophageal carcinoma. Among the 11 patients who died of tumor recurrence, 10 died within 5 to 9 years of their esophagectomy. The incidence of various modes of tumor recurrence among these 18 patients was as follows: blood-borne metastasis, 61%; lymph node recurrence, 33%; and locoregional organ recurrence, 33%. Factors that may be pertinent to a higher tumor recurrence rate include male sex, moderate to poor tumor differentiation, the presence of lymph node metastasis, and late stage of disease (stage IIb or worse). However, we could not find any statistical significance among these possible factors. These results suggest that the character of tumor recurrence in long-term survivors may differ from that in patients suffering from early tumor recurrence, and this may warrant further investigation. As time elapses, metachronous tumor resulting from an esophageal remnant or a secondary primary neoplasm originating from another site should be differentiated from primary tumor recurrence.

Original languageEnglish
Pages (from-to)677-681
Number of pages5
JournalAnnals of Thoracic Surgery
Volume57
Issue number3
DOIs
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Esophagus
Survivors
Carcinoma
Recurrence
Neoplasms
Therapeutics
Esophagectomy
Lymph Nodes
Neoplasm Metastasis
Squamous Cell Carcinoma
Radiotherapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. / Fahn, Huei Jyh; Wang, Liang Shun; Huang, Biing Shiun; Huang, Min Hsiung; Chien, Kwang Yu.

In: Annals of Thoracic Surgery, Vol. 57, No. 3, 1994, p. 677-681.

Research output: Contribution to journalArticle

Fahn, Huei Jyh ; Wang, Liang Shun ; Huang, Biing Shiun ; Huang, Min Hsiung ; Chien, Kwang Yu. / Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. In: Annals of Thoracic Surgery. 1994 ; Vol. 57, No. 3. pp. 677-681.
@article{16c5e7caf6944e88b559511491263b76,
title = "Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus",
abstract = "To evaluate the status of tumor, recurrence and the possible factors relevant to tumor recurrence among patients who survived more than 5 years after subtotal esophagectomy for the treatment of squamous cell carcinoma of the esophagus, a total of 104 patients who received treatment between 1959 and 1986 were reviewed. In 18 of these 104 patients, local or distant tumor recurrence developed, for a tumor recurrence rate of 17.3{\%}. Eleven (61.1{\%}) of these 18 patients eventually died of carcinomatosis despite further radiotherapy or chemotherapy, or both, and 4 patients with the disease are still alive. Three patients continue to survive after aggressive therapy was instituted for control of the locally recurrent tumor. Sixty-nine of the 104 patients are alive without tumor recurrence after the initial esophagectomy, and the remaining 17 patients died of miscellaneous causes. Tumor recurrence appears to be the most important factor affecting the prognosis in long-term survivors with resectable esophageal carcinoma. Among the 11 patients who died of tumor recurrence, 10 died within 5 to 9 years of their esophagectomy. The incidence of various modes of tumor recurrence among these 18 patients was as follows: blood-borne metastasis, 61{\%}; lymph node recurrence, 33{\%}; and locoregional organ recurrence, 33{\%}. Factors that may be pertinent to a higher tumor recurrence rate include male sex, moderate to poor tumor differentiation, the presence of lymph node metastasis, and late stage of disease (stage IIb or worse). However, we could not find any statistical significance among these possible factors. These results suggest that the character of tumor recurrence in long-term survivors may differ from that in patients suffering from early tumor recurrence, and this may warrant further investigation. As time elapses, metachronous tumor resulting from an esophageal remnant or a secondary primary neoplasm originating from another site should be differentiated from primary tumor recurrence.",
author = "Fahn, {Huei Jyh} and Wang, {Liang Shun} and Huang, {Biing Shiun} and Huang, {Min Hsiung} and Chien, {Kwang Yu}",
year = "1994",
doi = "10.1016/0003-4975(94)90566-5",
language = "English",
volume = "57",
pages = "677--681",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus

AU - Fahn, Huei Jyh

AU - Wang, Liang Shun

AU - Huang, Biing Shiun

AU - Huang, Min Hsiung

AU - Chien, Kwang Yu

PY - 1994

Y1 - 1994

N2 - To evaluate the status of tumor, recurrence and the possible factors relevant to tumor recurrence among patients who survived more than 5 years after subtotal esophagectomy for the treatment of squamous cell carcinoma of the esophagus, a total of 104 patients who received treatment between 1959 and 1986 were reviewed. In 18 of these 104 patients, local or distant tumor recurrence developed, for a tumor recurrence rate of 17.3%. Eleven (61.1%) of these 18 patients eventually died of carcinomatosis despite further radiotherapy or chemotherapy, or both, and 4 patients with the disease are still alive. Three patients continue to survive after aggressive therapy was instituted for control of the locally recurrent tumor. Sixty-nine of the 104 patients are alive without tumor recurrence after the initial esophagectomy, and the remaining 17 patients died of miscellaneous causes. Tumor recurrence appears to be the most important factor affecting the prognosis in long-term survivors with resectable esophageal carcinoma. Among the 11 patients who died of tumor recurrence, 10 died within 5 to 9 years of their esophagectomy. The incidence of various modes of tumor recurrence among these 18 patients was as follows: blood-borne metastasis, 61%; lymph node recurrence, 33%; and locoregional organ recurrence, 33%. Factors that may be pertinent to a higher tumor recurrence rate include male sex, moderate to poor tumor differentiation, the presence of lymph node metastasis, and late stage of disease (stage IIb or worse). However, we could not find any statistical significance among these possible factors. These results suggest that the character of tumor recurrence in long-term survivors may differ from that in patients suffering from early tumor recurrence, and this may warrant further investigation. As time elapses, metachronous tumor resulting from an esophageal remnant or a secondary primary neoplasm originating from another site should be differentiated from primary tumor recurrence.

AB - To evaluate the status of tumor, recurrence and the possible factors relevant to tumor recurrence among patients who survived more than 5 years after subtotal esophagectomy for the treatment of squamous cell carcinoma of the esophagus, a total of 104 patients who received treatment between 1959 and 1986 were reviewed. In 18 of these 104 patients, local or distant tumor recurrence developed, for a tumor recurrence rate of 17.3%. Eleven (61.1%) of these 18 patients eventually died of carcinomatosis despite further radiotherapy or chemotherapy, or both, and 4 patients with the disease are still alive. Three patients continue to survive after aggressive therapy was instituted for control of the locally recurrent tumor. Sixty-nine of the 104 patients are alive without tumor recurrence after the initial esophagectomy, and the remaining 17 patients died of miscellaneous causes. Tumor recurrence appears to be the most important factor affecting the prognosis in long-term survivors with resectable esophageal carcinoma. Among the 11 patients who died of tumor recurrence, 10 died within 5 to 9 years of their esophagectomy. The incidence of various modes of tumor recurrence among these 18 patients was as follows: blood-borne metastasis, 61%; lymph node recurrence, 33%; and locoregional organ recurrence, 33%. Factors that may be pertinent to a higher tumor recurrence rate include male sex, moderate to poor tumor differentiation, the presence of lymph node metastasis, and late stage of disease (stage IIb or worse). However, we could not find any statistical significance among these possible factors. These results suggest that the character of tumor recurrence in long-term survivors may differ from that in patients suffering from early tumor recurrence, and this may warrant further investigation. As time elapses, metachronous tumor resulting from an esophageal remnant or a secondary primary neoplasm originating from another site should be differentiated from primary tumor recurrence.

UR - http://www.scopus.com/inward/record.url?scp=0028295905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028295905&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(94)90566-5

DO - 10.1016/0003-4975(94)90566-5

M3 - Article

VL - 57

SP - 677

EP - 681

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -